Logo

Invitrogen Completes Molecular Probes Acquisition

Aug 22, 2003

NEW YORK, Aug. 22 (GenomeWeb News) - Invitrogen announced today that it had completed its acquisition of Molecular Probes.

 

"As a leader in life sciences consumables, we believe that Invitrogen's worldwide sales, marketing and distribution capabilities will accelerate the penetration of Molecular Probes' core technologies into new markets," said Invitrogen CEO Greg Lucier in a statement that also reaffirmed the company's financial guidance for 2003.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.